Patients’ treatment limitations as predictive factor for mortality in COVID-19: results from hospitalized patients of a hotspot region for SARS-CoV-2 infections

Table 5 Predictors of mortality including the presence of at least one treatment limitation

Predictor	b	SE	OR	95% CI		p-value
Sex (female vs. male)	− 0.43	0.32	0.65	0.33	1.17	0.161
Age	0.00	0.02	1.00	0.97	1.04	0.893
PAD	0.35	0.57	1.42	0.52	4.31	0.510
Cardiovascular disease	− 0.39	0.39	0.68	0.28	1.32	0.281
Obstructive airway disease	− 0.17	0.46	0.84	0.30	1.99	0.681
Malignant disease	− 0.27	0.44	0.76	0.30	1.65	0.531
Dementia	0.27	0.43	1.31	0.55	2.97	0.508
CCI	0.21	0.09	1.24	1.07	1.51	0.010
eGFR ≤ 55 (ml/min)	0.75	0.35	2.11	1.12	4.35	0.020
SpO₂ ≤ 93%	0.73	0.31	2.08	1.20	3.94	0.012
Neutrophils ≥ 5 (G/l)	0.69	0.33	1.99	1.06	3.97	0.027
CRP ≥ 7 (mg/dl)	1.70	0.34	5.49	3.32	12.43	0.001
Limitation (at least one)	1.47	0.45	4.34	2.10	12.30	0.001

For the definition of abbreviations see Tables 2, 3. The results shown are based on 439 patients having complete data for all of the predictors included
Bold p-values represent statistical significance (< 0.05)

ISSN: 1465-993X